Casdin Capital as of Sept. 30, 2016
Portfolio Holdings for Casdin Capital
Casdin Capital holds 26 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Agios Pharmaceuticals (AGIO) | 12.1 | $15M | 282k | 52.82 | |
| Sage Therapeutics (SAGE) | 9.9 | $12M | 267k | 46.05 | |
| Foundation Medicine | 7.8 | $9.7M | 415k | 23.35 | |
| Evolent Health (EVH) | 7.7 | $9.5M | 385k | 24.62 | |
| Blueprint Medicines (BPMC) | 6.9 | $8.5M | 287k | 29.70 | |
| Loxo Oncology | 6.2 | $7.6M | 291k | 26.18 | |
| GenMark Diagnostics | 6.0 | $7.4M | 625k | 11.80 | |
| Spark Therapeutics | 4.5 | $5.6M | 94k | 60.06 | |
| Global Blood Therapeutics In | 4.5 | $5.5M | 240k | 23.05 | |
| Kite Pharma | 4.1 | $5.0M | 90k | 55.86 | |
| Bluebird Bio | 3.3 | $4.1M | 60k | 67.78 | |
| Clovis Oncology | 3.2 | $4.0M | 110k | 36.05 | |
| Voyager Therapeutics (VYGR) | 2.7 | $3.3M | 277k | 12.01 | |
| Epizyme | 2.4 | $2.9M | 295k | 9.84 | |
| EXACT Sciences Corporation (EXAS) | 2.3 | $2.9M | 155k | 18.57 | |
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $2.6M | 39k | 67.77 | |
| Allscripts Healthcare Solutions (MDRX) | 2.1 | $2.6M | 200k | 13.17 | |
| Myokardia | 2.1 | $2.6M | 160k | 16.34 | |
| Genomic Health | 2.1 | $2.6M | 90k | 28.92 | |
| Medgenics | 1.7 | $2.1M | 375k | 5.57 | |
| Cytomx Therapeutics (CTMX) | 1.6 | $2.0M | 128k | 15.68 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.2 | $1.4M | 5.0k | 289.40 | |
| Ignyta | 1.0 | $1.2M | 195k | 6.29 | |
| Ionis Pharmaceuticals (IONS) | 1.0 | $1.2M | 33k | 36.64 | |
| Editas Medicine (EDIT) | 0.9 | $1.2M | 86k | 13.48 | |
| Syros Pharmaceuticals | 0.6 | $694k | 50k | 13.88 |
